Lonsec: Subscribe recommendation on Medibank
Lonsec Stockbroking has released a research report on Medibank Private Limited (MPL) delivering a subscribe recommendation to advisors and investors for Australia's largest privatisation since Telstra.
Lonsec says it expects Medibank to generate 6% p.a. compounded earnings growth over FY15-17 and offer a yield of around 4.0% fully franked.
It also provides FY16 valuation target of $2.33/share - representing a 16-50% premium to the proposed price range.
Read more about the Lonsec recommendation...
|